Status:
COMPLETED
A Study of Preferences for the First-Line Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
Carcinoma, Non-Small-Cell Lung
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this observational study is to determine participants' preferences for outcomes associated with first-line treatment of advanced/metastatic Non-Small Cell Lung Cancer (NSCLC) using a di...
Eligibility Criteria
Inclusion
- The following is the inclusion criteria for pretest interviews and final online survey.
- Participants:
- Must be 18 years of age or older
- Must be a US resident.
- Lung cancer participants with a physician diagnosis of NSCLC. Global Perspectives will be involved to suggest alternative strategies to a physician-confirmed diagnosis to ensure that actual cancer participants are recruited.
Exclusion
- Not applicable
- Other protocol-defined inclusion/exclusion criteria apply
Key Trial Info
Start Date :
December 9 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 4 2023
Estimated Enrollment :
501 Patients enrolled
Trial Details
Trial ID
NCT05250817
Start Date
December 9 2021
End Date
January 4 2023
Last Update
June 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
RTI Health Solutions
Research Triangle Park, North Carolina, United States, 27709